- Home
- MVBF vs CERS Comparison
MVBF vs CERS Comparison
Compare MVBF & CERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MVBF
- CERS
- Stock Information
- Founded
- MVBF 1997
- CERS 1991
- Country
- MVBF United States
- CERS United States
- Employees
- MVBF N/A
- CERS N/A
- Industry
- MVBF Major Banks
- CERS EDP Services
- Sector
- MVBF Finance
- CERS Technology
- Exchange
- MVBF Nasdaq
- CERS Nasdaq
- Market Cap
- MVBF 278.3M
- CERS 271.4M
- IPO Year
- MVBF N/A
- CERS 1997
- Fundamental
- Price
- MVBF $23.21
- CERS $1.50
- Analyst Decision
- MVBF Buy
- CERS Strong Buy
- Analyst Count
- MVBF 3
- CERS 2
- Target Price
- MVBF $24.67
- CERS $3.50
- AVG Volume (30 Days)
- MVBF 52.3K
- CERS 1.4M
- Earning Date
- MVBF 07-28-2025
- CERS 07-31-2025
- Dividend Yield
- MVBF 3.02%
- CERS N/A
- EPS Growth
- MVBF N/A
- CERS N/A
- EPS
- MVBF 1.46
- CERS N/A
- Revenue
- MVBF $146,101,000.00
- CERS $185,144,000.00
- Revenue This Year
- MVBF N/A
- CERS $24.95
- Revenue Next Year
- MVBF $14.22
- CERS $8.48
- P/E Ratio
- MVBF $15.44
- CERS N/A
- Revenue Growth
- MVBF N/A
- CERS 13.06
- 52 Week Low
- MVBF $15.59
- CERS $1.12
- 52 Week High
- MVBF $25.24
- CERS $2.54
- Technical
- Relative Strength Index (RSI)
- MVBF 80.99
- CERS 54.05
- Support Level
- MVBF $20.26
- CERS $1.31
- Resistance Level
- MVBF $22.72
- CERS $1.46
- Average True Range (ATR)
- MVBF 0.52
- CERS 0.07
- MACD
- MVBF 0.16
- CERS 0.00
- Stochastic Oscillator
- MVBF 99.08
- CERS 65.79
About MVBF MVB Financial Corp.
MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.
About CERS Cerus Corporation
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.